Market Cap

Myovant Sciences Ltd. Market Capitalization:

$2.61 Billion

USD as of Jan. 1, 2023

business Myovant Sciences Ltd. Company Profile

Myovant Sciences Ltd. Main Stock Listing

NYSE: MYOV

Market Capitalization History of Myovant Sciences Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Myovant Sciences Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $2.61 B 106.16%
Jan. 1, 2022 $1.27 B -43.92%
Jan. 1, 2021 $2.26 B 83.39%
Jan. 1, 2020 $1.23 B -31.13%
Jan. 1, 2019 $1.79 B 31.90%
Jan. 1, 2018 $1.35 B 25.49%
Jan. 1, 2017 $1.08 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Myovant Sciences Ltd. Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Myovant Sciences Ltd. has the following listings and related stock indices.


Stock: NYSE: MYOV

Stock: FSX: 71M

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.